Affiliate Disclosure
Nortixa's declared business model is affiliate. This build has no active affiliate offer links because no partner or commercial CTA destination was provided.
Effective: 6 October 2026 · Last updated: 6 October 2026
1. What an affiliate relationship means
An affiliate arrangement is a commercial relationship in which a publisher may receive a commission or other agreed compensation when a reader follows a specially identified link and completes an eligible action with another business. Affiliate compensation is a funding mechanism; it is not evidence that a product or service is medically effective.
A useful disclosure should tell the reader that compensation may exist, make the commercial nature of a link visible, and avoid creating the impression that the third-party business is part of Nortixa unless that is factually true.
2. Current status of nortixa.online
The project input identifies the business model as affiliate, but no affiliate network or partner name was provided and no CTA URL was provided. Nortixa therefore has no active affiliate offer link, no partner redirect and no affiliate tracking parameter configured in this supplied build.
External links on the Resources and Media Credits pages point to public sources for verification and attribution. They are not represented as commercial affiliate links.
3. Requirements for future affiliate links
If affiliate links are introduced later, the partner and destination must be real. A commercial button should describe honestly what happens after the click. A user should not be told that a link is “medical advice”, “doctor approved” or “required treatment” unless there is a lawful, verifiable basis for that statement.
Disclosure should be placed where a reasonable reader can see it before or at the point of the commercial decision. A disclosure hidden only in a footer while the article aggressively promotes a paid destination would not meet Nortixa's intended transparency standard.
4. Affiliate tracking and privacy
Many affiliate systems use query parameters, cookies, pixels or server-side identifiers to attribute a conversion. None is active in this build. Before introducing tracking, the operator should review the actual data flow: what identifier is set, which third party receives it, whether personal data is involved, how long attribution lasts, and whether cross-border transfer or consent requirements arise.
The Privacy and Cookie policies must be updated if the real implementation changes. A future affiliate network should not be silently added while the legal pages continue to claim that no tracking exists.
5. Editorial independence
Nortixa's health explanations should be written independently of whether a product pays commission. Clinical facts should be drawn from appropriate evidence, and uncertainty should remain visible where evidence is uncertain. A paid relationship must not cause the site to exaggerate the prevalence, severity or treatability of prostatitis.
Editorial pages should distinguish a general explanation of symptoms and care from any later commercial recommendation. Affiliate compensation should never determine the wording of urgent-care warnings.
6. Comparisons, “best” claims and reviews
Nortixa should not publish invented star ratings, review counts, patient testimonials or “best product” rankings. If products or services are compared in future, the comparison method, material criteria and commercial relationships should be explained. A ranking should not be presented as objective clinical evidence when it is actually based on commission value.
No reviews or ratings have been supplied for the current site, so none are present.
7. Medical-content boundary
Prostatitis can involve bacterial infection, chronic pelvic pain or other clinical patterns. An affiliate product should never be promoted as a guaranteed cure for all forms. A supplement, device or service cannot replace urgent care for complete urinary retention or urinary symptoms with fever/chills, blood in urine or severe pain.
If a commercial product has risks, contraindications, age restrictions or regulatory limitations, those should not be concealed. Nortixa should never encourage a reader to stop prescribed treatment in order to use an affiliate product.
8. Price, availability and user choice
If a future commission does not change the price paid by the user, that may be stated when verified. If a partner arrangement does affect price, availability or eligibility, the disclosure should explain that accurately. Prices and stock can change, so claims such as “cheapest” or “always available” should not be made without current evidence.
A reader remains free to ignore a commercial link, seek another provider or use only the educational content.
9. Sponsored content and other compensation
If Nortixa later receives a fixed sponsorship fee, free product, paid placement or other material benefit, that relationship should be disclosed even when no affiliate link is used. “Affiliate” should not be used as a blanket label that hides a different type of sponsorship.
10. Corrections and conflicts
If an affiliate relationship creates a factual conflict or a product claim becomes outdated, Nortixa should correct the content rather than preserve a misleading statement to protect revenue. Material commercial relationships should be re-checked when links or partners change.
11. Contact
Questions about commercial relationships or disclosure can be sent to [email protected]. Partnership messages should not include personal health information.